From Screens to Support: Re‐Engineering Cancer Nursing Practice With Telemedicine

Dear Editor,

The rigorous meta‐analysis by Su and colleagues, published in the Journal of Clinical Nursing, offers more than a definitive quantitative evaluation of telemedicine's impacts on cancer patients (Su et al. 2026). It provides a rare and critical dissection of the fundamental challenge facing digital oncology nursing: the transition from empirical evidence of telemedicine's efficacy to its equitable and contextually adaptive clinical integration. While the authors meticulously demonstrate telemedicine's positive effects on distress, physical function and self‐efficacy in cancer patients, their work inadvertently exposes the deeper socio‐clinical fissures that will determine the success or failure of telemedicine in delivering sustainable, person‐centred cancer care at the bedside.

The study's primary strength lies not in its statistically significant effect sizes, but in its rigorous methodological portrayal of telemedicine as a complementary rather than a substitutive care process. The finding that telemedicine yields marked improvements in distress (SMD = −0.44, p < 0.00001) and self‐efficacy (SMD = 0.46, p < 0.0001) with stable sensitivity analyses underscores a crucial truth: effective clinical telemedicine acts not as a replacement for in‐person cancer nursing, but as a catalyst for extending care access and empowering patients to engage in self‐management. The clear classification of telemedicine interventions into three practical forms—smartphone apps, internet‐based mHealth tools and combined digital interventions—suggests that when embedded within established cancer care workflows, digital remote support can successfully recalibrate clinical practice to address the unmet psychological and self‐management needs of cancer patients. This is a significant lesson for the field, shifting the research paradigm from one of pure efficacy testing to one of practical intervention design within real‐world nursing workflows.

However, the study also surfaces tensions that the current telemedicine research framework may be ill‐equipped to fully address. The modest improvement in physical function (SMD = 0.11, p = 0.04) and the reversal of pooled results after excluding three large‐sample studies are not mere statistical nuances; they are symptoms of a profound clinical and methodological clash. Cancer nursing for physical function is inherently holistic, personalised and stage‐adapted, tailored to a patient's cancer type, treatment phase and individual physical capacity. Telemedicine research, as presented here, is aggregate, intervention‐heterogeneous and outcome‐measure variable—with physical function assessed via four distinct scales and interventions varying in duration from 6 to 24 weeks. The authors note the weak effect on physical function but do not fully address the why behind this inconsistency. This is not a demand for more statistical analysis; it is a professional demand for clinical accountability. When a nurse designs a remote physical rehabilitation plan for a cancer patient, the inability to discern which telemedicine modalities work for which patient subgroups undermines the very clinical reasoning the tool aims to augment (Goncalves Leite Rocco et al. 2024). Future telemedicine research must incorporate subgroup stratification by cancer type, treatment stage and patient characteristics as a core clinical feature, not a supplementary analysis.

Furthermore, the study hints at, but does not fully grapple with, the risk of digital complacency and inequity in cancer nursing practice. If oncology nurses begin to rely on telemedicine data to monitor patient physical function and psychological distress, what becomes of the foundational nursing skill of in‐person, holistic assessment—one that captures subtle physical and emotional cues lost in remote digital monitoring? The authors acknowledge that 79% of participants are female and most included studies are from Western countries, which is reassuring in its transparency but also raises the question: could the overreliance on homogeneous study populations erode the generalisability of telemedicine evidence for underrepresented groups, such as male cancer patients or those from low‐ and middle‐income contexts (Bakker et al. 2023)? The meta‐analysis's cross‐sectional design cannot answer this. The ethical imperative is to design telemedicine that enhances, rather than dilutes, core nursing assessment skills and that is equitable in its applicability to diverse cancer patient populations.

Finally, the study stops at the nurse‐telemedicine interface. The next frontier for telemedicine in cancer care is the patient–nurse–telemedicine triad. The authors wisely suggest future research in different cultural contexts and long‐term follow‐up, but truly patient‐centred telemedicine would not only support nurses in delivering remote care but could also, with careful design, empower patients as active participants in their care. For example, by providing personalised, understandable feedback on their own self‐management progress or co‐designing remote intervention goals with nurses and patients. This transforms telemedicine from a care task performed for patients to a care partnership enabled with patients—a shift central to modern person‐centred nursing (Hickmann et al. 2022).

In conclusion, Su and colleagues have successfully built a robust evidence base for telemedicine in cancer care and a clear methodological playbook for future meta‐analyses. Their greater contribution, however, is lighting a path for the essential next phase of oncology nursing research: moving beyond efficacy assessment to examine how telemedicine reshapes the ecology of cancer care. We must now ask harder questions about preserving core nursing assessment skills in a digital care environment, engineering subgroup‐specific telemedicine interventions for diverse cancer patients, and measuring the long‐term evolution of patient–nurse relationships in a telemedicine‐assisted setting. The promise of telemedicine in cancer nursing is not just in reducing distress or improving self‐efficacy, but in fostering a new, more resilient, and collaborative model of clinical care that combines digital technology with the humanistic core of oncology nursing. This meta‐analysis is an excellent first step on that much longer journey.

Funding

The authors have nothing to report.

Ethics Statement

The authors have nothing to report.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The authors have nothing to report.